JPRN-UMIN000014544招募中1 期
Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2 - Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Symptomatic brain metastasis 2) Interstitial pneumonia with usual interstitial pneumonia pattern on chest CT 3) Grade 2 or more peripheral sense neuropathy 4) With uncontrolled pleural effusion, ascites or pericardial effusion 5) Treated with palliative radiotherapy within the past two weeks 6) Active concomitant malignancy 7) Severe complication 8) HBs antigen positive 9) Previous severe drug allergy 10) Continuous systemic administration of steroid
研究者
相似试验
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
已完成
1 期
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancernon small cell lung cancerJPRN-UMIN000013223Kochi University12
招募中
1 期
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
已完成
2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
